CLINUVEL PHARM LTD earnings per share and revenue

UR9 earnings per share for the last semiannual are 0.12 CHF whereas the estimation was 0.15 CHF which accounts for -17.65% surprise. Företagets omsättning för samma period uppgår till 18.49 M CHF trots den uppskattade siffran 19.95 M CHF. Estimated earnings per share for the next semiannual are 0.24 CHF, and revenue is expected to reach 32.27 M CHF. Also watch annual changes over time to get a bigger picture of UR9 earnings per share and revenue dynamics.